Cargando…
Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression
Malignant peripheral nerve sheath tumor (MPNST) in the thorax is an extremely rare disease, and half of all cases of MPNST are associated with neurofibromatosis type I. Sporadic intrathoracic MPNST is difficult to diagnose and treat. Because of the rarity of intrathoracic MPNST, the optimal method o...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668470/ https://www.ncbi.nlm.nih.gov/pubmed/28876532 http://dx.doi.org/10.1111/1759-7714.12498 |
_version_ | 1783275678311907328 |
---|---|
author | Seno, Noriko Fukushima, Toshirou Gomi, Daisuke Kobayashi, Takashi Sekiguchi, Nodoka Matsushita, Hidehiro Ozawa, Takesumi Tsukahara, Yoshiko Mamiya, Keiko Koizumi, Tomonobu Sano, Kenji |
author_facet | Seno, Noriko Fukushima, Toshirou Gomi, Daisuke Kobayashi, Takashi Sekiguchi, Nodoka Matsushita, Hidehiro Ozawa, Takesumi Tsukahara, Yoshiko Mamiya, Keiko Koizumi, Tomonobu Sano, Kenji |
author_sort | Seno, Noriko |
collection | PubMed |
description | Malignant peripheral nerve sheath tumor (MPNST) in the thorax is an extremely rare disease, and half of all cases of MPNST are associated with neurofibromatosis type I. Sporadic intrathoracic MPNST is difficult to diagnose and treat. Because of the rarity of intrathoracic MPNST, the optimal method of diagnosis and the efficacy of chemotherapy are unknown. Herein, we present a case of inoperable mediastinal MPNST, in which the diagnosis was immunohistochemically made by the loss of H3K27me3 expression in a transbronchial needle biopsy specimen. The patient showed a good response to doxorubicin plus ifosfamide chemotherapy. The present case highlights that MPNST should be included in the differential diagnosis of non‐posterior mediastinum thoracic lesions, and that appropriate diagnosis and treatment for intrathoracic MPNST should be considered in patients with a thoracic mass. |
format | Online Article Text |
id | pubmed-5668470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-56684702017-11-09 Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression Seno, Noriko Fukushima, Toshirou Gomi, Daisuke Kobayashi, Takashi Sekiguchi, Nodoka Matsushita, Hidehiro Ozawa, Takesumi Tsukahara, Yoshiko Mamiya, Keiko Koizumi, Tomonobu Sano, Kenji Thorac Cancer Case Reports Malignant peripheral nerve sheath tumor (MPNST) in the thorax is an extremely rare disease, and half of all cases of MPNST are associated with neurofibromatosis type I. Sporadic intrathoracic MPNST is difficult to diagnose and treat. Because of the rarity of intrathoracic MPNST, the optimal method of diagnosis and the efficacy of chemotherapy are unknown. Herein, we present a case of inoperable mediastinal MPNST, in which the diagnosis was immunohistochemically made by the loss of H3K27me3 expression in a transbronchial needle biopsy specimen. The patient showed a good response to doxorubicin plus ifosfamide chemotherapy. The present case highlights that MPNST should be included in the differential diagnosis of non‐posterior mediastinum thoracic lesions, and that appropriate diagnosis and treatment for intrathoracic MPNST should be considered in patients with a thoracic mass. John Wiley & Sons Australia, Ltd 2017-09-06 2017-11 /pmc/articles/PMC5668470/ /pubmed/28876532 http://dx.doi.org/10.1111/1759-7714.12498 Text en © 2017 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Seno, Noriko Fukushima, Toshirou Gomi, Daisuke Kobayashi, Takashi Sekiguchi, Nodoka Matsushita, Hidehiro Ozawa, Takesumi Tsukahara, Yoshiko Mamiya, Keiko Koizumi, Tomonobu Sano, Kenji Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression |
title | Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression |
title_full | Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression |
title_fullStr | Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression |
title_full_unstemmed | Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression |
title_short | Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression |
title_sort | successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of h3k27me3 expression |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668470/ https://www.ncbi.nlm.nih.gov/pubmed/28876532 http://dx.doi.org/10.1111/1759-7714.12498 |
work_keys_str_mv | AT senonoriko successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT fukushimatoshirou successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT gomidaisuke successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT kobayashitakashi successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT sekiguchinodoka successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT matsushitahidehiro successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT ozawatakesumi successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT tsukaharayoshiko successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT mamiyakeiko successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT koizumitomonobu successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression AT sanokenji successfultreatmentwithdoxorubicinandifosfamideformediastinalmalignantperipheralnervesheathtumorwithlossofh3k27me3expression |